Asian shares mostly advanced Tuesday after President Donald Trump delayed raising tariffs on China for another 90 days.

白宮分別與晶片商英偉達與AMD達成協議，要求兩家公司就銷往中國的晶片銷售收入繳交 ...

The US and China have extended their trade truce until 10 November, just hours before a jump in tariffs had been set to take ...

Maravai LifeSciences (MRVI) delivered earnings and revenue surprises of -33.33% and -2.23%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Aquestive Therapeutics (AQST) delivered earnings and revenue surprises of +22.22% and -9.62%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

日股假期後復市，初段創新高。 日經指數較早時報42431點，升611點，升幅1.46%。

Karyopharm Therapeutics (KPTI) delivered earnings and revenue surprises of -13.68% and -5.37%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock ...

嶺南大學在7月以1.17億元購入屯門青棉徑2號菁雋地下入口、1樓和2樓商場、3個地舖及停車場，呎價約2,983元，主要作為教學用途。該物業總建築面積合共約39,228方呎，停車場提供47個私家車位及5個電單車位。 據悉，上述物業原由「舖王」鄧成波家族持有，早於2022年於市場上放售，曾叫價3.88億元，去年8月減至2億元。惟有關物業去年9月遭接管，銀主把物業放售近一年後沽出。 此外，鄧成波家族持有 ...

開拓藥業(09939.HK)公布，其自主研發的新型靶向雄激素受體(AR)的蛋白降解嵌合體(PROTAC)化合物GT20029治療痤瘡的該項II期臨床試驗讀出頂線數據。數據顯示，該項II期臨床試驗成功達到主要研究終點，結果具有統計學顯著性及臨床意義，且 ...

FibroGen (FGEN) delivered earnings and revenue surprises of -50.22% and -53.52%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Wendy Cutler, Asia Society Policy Institute Vice President and Former Acting Deputy US Trade Representative, talks about ...

中國物流與採購聯合會公布數據顯示，在促消費政策的支持下，電商物流持續活躍，7月中國電商物流指數為112，比上月回升0.2點，再創年內新高。